University News

Previous Articles
2014
January
February
March
April
May
June
July
August
September
October
November
December
2013
January
February
March
April
May
June
July
August
September
October
November
December
2012
January
February
March
April
May
June
July
August
September
October
November
December

Q&A with Dr. Perman

The Daily Record named University of Maryland, Baltimore (UMB) President, Jay A. Perman, MD one of Marylandýs Most Admired CEOs for 2013. The award recognizes men and women for both professional excellence and service to their communities. Nominees were evaluated on leadership, competitiveness, business growth, vision and community leadership.

"The word 'admired' is the most important part here," says Suzanne Fischer-Huettner, Publisher of The Daily Record. "Other events are held on the level of you're better than your peers. This one is more of, the people who work for you, the people who want you on their boards, the community admire you for what youýre doing, which is a huge compliment."

In addition to serving as president of the University of Maryland, Baltimore, Perman continues to see patients weekly in his pediatric gastroenterology practice, and serves the community on the board of directors of the Downtown Partnership of Baltimore, the Hippodrome Foundation and the University of Maryland Medical System, and as co-chair with Mayor Stephanie Rawlings-Blake of the Westside Task Force.

What sets Perman apart, however, is his vision of leadership. "I champion teamwork and collaboration as an important means to achieve organizational outcomes - be they professional competencies arising from our educational programs, cutting edge research or service to humankind," he says. "In fact, these outcomes define our mission at the University of Maryland, Baltimore."

Perman's emphasis on teamwork has delivered some impressive results in just the first three years of his presidency. A partnership with the University of Maryland, College Park (UMCP), The University of Maryland: MPowering the State, has been key to expanding educational offerings and making the most of UMB's expertise and resources, such as:

The first courses will be offered next year in a collaborative school of public health involving faculty and facilities at the School of Medicine in Baltimore and the School of Public Health in College Park.

UM Ventures, a joint effort to help commercialize the $1 billion in grant-based research conducted by the two campuses, is on target to create 300 new technology companies over ten years.

The new Center for Health-Related Informatics and BioImaging (CHIB) is helping computer scientists from College Park and genomics and clinical medicine researchers in Baltimore work to better understand diseases such as autism, cancer and diabetes.

The Institute for a Healthiest Maryland is playing a key role in improving wellness across the state by fighting obesity, tobacco use, hypertension and high cholesterol.

Partnering with the FDA, the two universities are modernizing and improving the ways drugs and medical devices are reviewed and approved. Researchers are working with FDA staff to support the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.

Perman also sees success in implementing major upgrades to UMB's capabilities.

Within two years the university will be treating cancer patients in the only advanced proton therapy clinic in the Mid-Atlantic. In the $200-million privately funded facility radiation will be focused precisely on tumors, promising lifesaving treatment while minimizing the risk of damaging healthy tissue.

This summer, construction will begin on a new 330-thousand square foot health sciences facility that will add new laboratories, a nano-medicine suite, high-end bio-imaging and classroom space. This $265 million investment will enable the university to expand health science degree programs and help fill Maryland's growing demand for doctors, dentists, nurses and pharmacists.

Perman also anticipates building a third 200,000 square foot facility in the BioPark, a community of life science companies and academic research centers where new drugs, devices and diagnostics are commercialized, and advances are made in biomedical research.

"By encouraging innovation and collaboration, my goal is to not only improve the quality of education and the capabilities of our graduates," Perman says, "but to leverage our resources and abilities for the betterment of Marylanders' health and prosperity. And as we advance this cause, we strengthen the reputation of the University of Maryland, Baltimore, a principal anchor institution for our city, as one of the nation's premier academic research institutions, paving the way for even greater success."
Posting Date: 07/19/2013
Contact Name: Alex Likowski
Contact Email: alikowski@umaryland.edu